Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Soheil Jamshidi

Vascular Surgery Suwanee, GA Medical Doctor

NPI 1679189443 CMS profile 8245900

2685 Peachtree Pkwy Ste 320, Suwanee, GA 30024

Open in the dashboard

General payments

$1,453

54 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Soheil Jamshidi of Suwanee, GA is reported in the CMS Open Payments database as having received $1,453 across 54 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 25th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $56 2
2024 General $32 1
2023 General $252 22
2022 General $553 16
2021 General $425 12
2020 General $134 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Soheil Jamshidi
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Soheil Jamshidi were reported at $56. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Soheil Jamshidi Vascular Surgery median Middle half National median
2019 $0 $796 $226–$2,363 $163
2020 $134 $348 $118–$1,110 $114
2021 $425 $471 $158–$1,421 $132
2022 $553 $725 $222–$2,183 $149
2023 $252 $836 $257–$2,440 $160
2024 $32 $909 $252–$2,619 $164
2025 $56 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Medtronic, Inc. $290 26 payments
  2. AngioDynamics, Inc. $249 3 payments
  3. Janssen Pharmaceuticals, Inc $175 5 payments
  4. Philips Electronics North America Corporation $165 3 payments
  5. Boston Scientific Corporation $163 6 payments
  6. Shockwave Medical, Inc $125 1 payment
  7. Baxter Healthcare $116 1 payment
  8. Pfizer Inc. $37 2 payments
  9. Endologix, Inc. $35 1 payment
  10. Bard Peripheral Vascular, Inc. $34 2 payments
  11. Other $66 4 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $1,453 54 payments
Products named General payments · program years 2020–2025
  1. VENASEAL $224 21 payments
  2. XARELTO $175 5 payments
  3. Vascular Lithotripsy $125 1 payment
  4. FLOSEAL $116 1 payment
  5. Varithena Administration Pack $103 3 payments
  6. AURYON LASER SYSTEM 100-120 VAC $96 1 payment
  7. (9282) Turbo Power $93 1 payment
  8. (4067) Tack Endo Sys BTK $55 1 payment
  9. ELIQUIS $37 2 payments
  10. Alto Abdominal Stent Graft System $35 1 payment
  11. Other $242 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

54 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record